Amman, November 14, 2026: Deputizing for His Majesty King Abdullah II, HRH Prince Talal bin Muhammad honored the awardees of the 2026 King Hussein Cancer Research Award, in the presence of HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and Center (KHCC), and a number of other Royal Family members.
Princess Ghida gave a speech during the ceremony, stating: "Tonight, we come together to honor and celebrate the winners of the King Hussein Cancer Research Award — Arab scientists who demonstrate that discovery can begin right here, in the Arab world, and for the sake of our patients."
The King Hussein Award is presented annually to recognize researchers who have made outstanding contributions to cancer research, encourage research efforts aimed at improving prevention and treatment, and foster scientific collaboration at both the regional and international levels.
The ceremony honored a distinguished group of leading Arab scientists and researchers, selected from hundreds of applicants representing more than 26 countries, in recognition of their significant contributions to advancing cancer research and driving scientific progress.
During the ceremony, Prof. Nizar Tannir of The University of Texas MD Anderson Cancer Center was honored with the Award for Excellence in Cancer Research in recognition of his outstanding achievements in kidney cancer research and treatment.
Prof. Amer Zeidan of Yale Cancer Center received the Lifetime Achievement Award – International Track, while the Lifetime Achievement Award – Regional Track was presented to Prof. Imam Waked of Menoufia University.
The Young Investigator Award – International Track was presented to Dr. Myriam Chalabi of the Netherlands Cancer Institute, while Prof. Omneya Attallah of the Arab Academy for Science, Technology and Maritime Transport received the Young Investigator Award – Regional Track.
The Promising Researcher Grant was awarded to both Dr. Zaid Abdel-Rahman of King Hussein Cancer Center and Dr. Philippe Kobeissy of the Lebanese American University, to fund their upcoming cancer research projects.
The Professional Development Program for Cancer Care Excellence was awarded to the Bone Marrow and Stem Cell Transplantation Program at the King Hussein Cancer Center, which performs more than 200 bone marrow transplants annually, with success rates exceeding 75%.
The King Hussein Cancer Research Award is one of the most prestigious scientific research awards in the field of cancer across the Arab world. Established in 2020 in memory of His Majesty the late King Hussein bin Talal, the award aims to encourage Arab researchers and scientists from around the world to elevate cancer research and advance the fight against cancer and overcome it through cutting-edge scientific approaches.
Since its launch five years ago, the award has contributed to building a strong and established Arab research community, receiving more than 950 applications from over 30 countries, all evaluated by more than 15 international experts in cancer research and oncology.
The 2026 ceremony was also attended by several ministers and members of the Award’s Board of Directors, comprising some of the world’s leading oncologists, physicians, and researchers, alongside prominent academic and media figures, as well as the award’s partners and supporters.